![](/img/cover-not-exists.png)
A randomized, phase 2 trial of cetuximab with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with metastatic colorectal carcinoma
Bowles, Daniel W., Kochenderfer, Mark, Cohn, Allen, Sideris, Lucas, Nguyen, Nghia, Cline-Burkhardt, Vivian, Schnadig, Ian, Choi, Minsig, Nabell, Lisle, Chaudhry, Arvind, Ruxer, Robert, Ucar, Antonio,Language:
english
Journal:
Clinical Colorectal Cancer
DOI:
10.1016/j.clcc.2016.03.004
Date:
March, 2016
File:
PDF, 1.47 MB
english, 2016